查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
无细胞 RNA 分离和提取试剂盒市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测，按应用、最终用户、公司和地区细分
市场调查报告书
商品编码
1321037

无细胞 RNA 分离和提取试剂盒市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测，按应用、最终用户、公司和地区细分

Cell Free RNA Isolation & Extraction Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application, By End User, By Company, and By Region
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球无细胞 RNA 分离和提取试剂盒市场在 2023-2027 年预测期内将出现令人印象深刻的增长。主要因素包括不同类型癌症发病率的上升和产前并发症病例的增加，这些都促进了市场的增长。无细胞 RNA 分离和提取试剂盒市场是一个成熟的市场，是医疗决策不可或缺的一部分，有助于获取广泛治疗传播的信息，强调其在医疗保健中的重要性。支持市场增长的其他因素包括老年人口基数的增加、广泛的研究和开发、患者群体对无创和微创方法的认识、政府投资的增加以及技术的进步。此外，生物技术和製药公司的战略伙伴关係和合作正在推动市场的增长。

癌症发病率增加

人口中肺癌、宫颈癌、乳腺癌等癌症的发病率不断增加，是市场增长的一个因素。癌症被认为是全球死亡和残疾的第二大原因。无细胞RNA存在于无细胞液体中，是在肿瘤脱落率较低的患者中检测肿瘤的机会。例如，2020年，国际癌症研究机构（IARC）发布的数据显示，全球每5人中有1人在一生中罹患癌症，每8名男性和11名女性中有1名死于癌症。根据其修订后的 GLOBOCAN 2020 报告，全球登记了大约 1,930 万个新癌症病例，1,000 万人死于癌症。因此，癌症患者数量的增加促进了无细胞 RNA 分离和提取试剂盒市场的增长。

产前并发症病例数量不断增加

过去几年，无创技术（例如有助于预测产前并发症的无细胞RNA）的应用取得了快速进展。宫内生长受限 (IUGR)、先兆子痫和自发性早产 (PTB) 等产前并发症可以通过无细胞 RNA (cf RNA) 进行表征和预测。例如，2014年至2018年间，妊娠并发症发生率上升超过16%，而分娩并发症发生率上升超过14%。每1,000 名孕妇中约有7 人患有妊娠糖尿病和先兆子痫并发症，自2014 年以来增加了近31%。因此，由于患有产前并发症的妇女人数增加，对无细胞RNA 分离和治疗的需求激增。提取套件正在推动市场的增长。

市场细分

全球无细胞 RNA 分离和提取试剂盒市场分为应用程序、最终用户和公司。根据应用，市场分为肿瘤学、产前筛查、代谢紊乱等。根据最终用户，市场分为医院和诊所、製药和生物技术公司等。就国家而言，由于美国癌症患病率不断上升，预计在预测期内美国将成为一个利润丰厚的市场。

市场参与者

F.Hoffmann-La Roche AG、JBS Science Inc.、Aline Biosciences、Apostle Inc. (Apostle Sciences)、Danagen-Bioted, SL、Norgen Biotek Corp.、PerkinElmer, Inc.、Promega Corporation、QIAGEN NV 和 Thermo Fisher Scientific Inc . 是市场上运营的一些领先公司。

可用的定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球无细胞 RNA 分离和提取试剂盒市场的影响

第 5 章：客户之声

第 6 章：全球无细胞 RNA 分离和提取试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按应用（肿瘤学、产前筛查、代谢紊乱、其他）
    • 按最终用户（医院和诊所、製药和生物技术公司、其他）
    • 按公司划分 (2021)
    • 按地区
  • 市场地图

第 7 章：北美无细胞 RNA 分离和提取试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 8 章：欧洲无细胞 RNA 分离和提取试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章：亚太地区无细胞 RNA 分离和提取试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 10 章：南美无细胞 RNA 分离和提取试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章：中东和非洲无细胞 RNA 分离和提取试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非无细胞 RNA 分离和提取试剂盒
    • 沙特阿拉伯无细胞 RNA 分离和提取试剂盒
    • UAE 无细胞 RNA 分离和提取试剂盒
    • 火鸡无细胞 RNA 分离和提取试剂盒
    • 埃及 无细胞 RNA 分离和提取试剂盒

第 12 章：市场动态

  • 司机
  • 挑战

第 13 章：市场趋势与发展

第14章：竞争格局

  • 霍夫曼罗氏公司
  • JBS 科学公司
  • 艾琳生物科学公司
  • 使徒公司（使徒科学）
  • Danagen-Bioted，SL
  • 诺根生物技术公司
  • 珀金埃尔默公司
  • 普洛麦格公司
  • 凯杰公司
  • 赛默飞世尔科技公司

第 15 章：战略建议

简介目录
Product Code: 12993

The global cell-free RNA isolation & extraction kits market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising incidences of different types of cancer and a growing number of cases of prenatal complications, which are bolstering the growth of the market. The cell-free RNA isolation and extraction kits market is a well-established market with an integral part of medical decision-making, which aids in obtaining information for a wide range of treatment dissemination, emphasizing their cruciality in healthcare. The other factors supporting the market's growth are the rising geriatric population base, extensive research, and development, awareness among the patient population about non-invasive and minimally invasive methods, increasing government investments, and technological advancements. Also, strategic partnerships and collaborations by biotechnology and pharmaceutical companies are fueling the growth of the market.

Increasing Incidence of Cancer

The growing occurrences of cancer, such as lung cancer, cervical cancer, breast cancer, and others among the population, is a contributing factor to the growth of the market. Cancer is considered the second largest cause of mortality and disability across the globe. Cell-free RNA occurs in cell-free fluids and is an opportunity to detect tumors in patients with lower tumor-shedding rates. For instance, in 2020, data was released by the International Agency for Research on Cancer (IARC), which revealed that 1 in 5 people develop cancer in their lifetime, and 1 in 8 men and 1 in 11 women die from cancer globally. As per its revised GLOBOCAN 2020 report, roughly 19.3 million new cancer cases were registered, and 10 million people died from it across the globe. Thus, the increase in the number of patients suffering from cancer is bolstering the growth of the Cell-Free RNA Isolation & Extraction Kits Market.

Increasing Number of Cases with Prenatal Complications

Over the past few years, rapid advancements have been made in the application of non-invasive techniques such as cell-free RNA, which helps to predict prenatal complications. Prenatal complications such as intrauterine growth restriction (IUGR), preeclampsia, and spontaneous preterm birth (PTB) can be characterized and predicted by cell-free RNA (cf RNA). For instance, between 2014-2018, the pregnancy complications rates rose more than 16%, while childbirth complications rates rose more than 14%. Around seven out of every 1,000 pregnant women underwent gestational diabetes and preeclampsia complications, an almost 31% increase since 2014. Therefore, owing to the increase in the number of women suffering from prenatal complications, the surge in demand for cell-free RNA isolation and extraction kits is fueling the growth of the market.

Market Segmentation

The global cell-free RNA isolation & extraction kits market is segmented into application, end user, and company. Based on application, the market is divided into oncology, prenatal screening, metabolic disorders, and others. Based on end users, the market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising prevalence of cancer in the country.

Market Players

F.Hoffmann-La Roche AG, JBS Science Inc., Aline Biosciences, Apostle Inc. (Apostle Sciences), Danagen-Bioted, S.L., Norgen Biotek Corp., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global cell-free RNA isolation & extraction kits market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cell Free RNA Isolation & Extraction Kits Market, By Application:

  • Oncology
  • Prenatal Screening
  • Metabolic Disorders
  • Others

Cell Free RNA Isolation & Extraction Kits Market, By End User:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Cell Free RNA Isolation & Extraction Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in cell free RNA isolation & extraction kits market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cell Free RNA Isolation & Extraction Kits Market

5. Voice of Customer

6. Global Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Oncology, Prenatal Screening, Metabolic Disorders, Others)
    • 6.2.2. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.3. By Company (2021)
    • 6.2.4. By Region
  • 6.3. Market Map

7. North America Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End User
    • 7.3.2. Canada Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End User
    • 7.3.3. Mexico Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End User

8. Europe Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End User
    • 8.3.2. Germany Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End User
    • 8.3.3. United Kingdom Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End User
    • 8.3.4. Italy Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End User
    • 8.3.5. Spain Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End User

9. Asia-Pacific Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End User
    • 9.3.2. India Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End User
    • 9.3.3. Japan Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End User
    • 9.3.4. South Korea Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Application
        • 9.3.4.2.2. By End User
    • 9.3.5. Australia Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Application
        • 9.3.5.2.2. By End User

10. South America Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End User
    • 10.3.2. Argentina Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End User
    • 10.3.3. Colombia Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End User

11. Middle East and Africa Cell Free RNA Isolation & Extraction Kits Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Application
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Application
        • 11.3.1.2.2. By End User
    • 11.3.2. Saudi Arabia Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Application
        • 11.3.2.2.2. By End User
    • 11.3.3. UAE Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Application
        • 11.3.3.2.2. By End User
    • 11.3.4. Turkey Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Application
        • 11.3.4.2.2. By End User
    • 11.3.5. Egypt Cell Free RNA Isolation & Extraction Kits Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Application
        • 11.3.5.2.2. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. F.Hoffmann-La Roche AG
  • 14.2. JBS Science Inc.
  • 14.3. Aline Biosciences
  • 14.4. Apostle Inc. (Apostle Sciences)
  • 14.5. Danagen-Bioted, S.L.
  • 14.6. Norgen Biotek Corp.
  • 14.7. PerkinElmer, Inc.
  • 14.8. Promega Corporation
  • 14.9. QIAGEN N.V.
  • 14.10. Thermo Fisher Scientific Inc.

15. Strategic Recommendations